CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis
TSX:CHR - Toronto Stock Exchange - CA17040T8885 - Common Stock - Currency: CAD
Overall CHR gets a fundamental rating of 5 out of 10. We evaluated CHR against 9 industry peers in the Passenger Airlines industry. CHR has only an average score on both its financial health and profitability. CHR has a bad growth rate and is valued cheaply. With these ratings, CHR could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
CHR had positive earnings in the past year.
In the past year CHR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CHR reported negative net income in multiple years.
CHR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of CHR (-17.42%) is comparable to the rest of the industry.
CHR's Return On Equity of -47.80% is in line compared to the rest of the industry. CHR outperforms 55.56% of its industry peers.
The Return On Invested Capital of CHR (6.29%) is better than 100.00% of its industry peers.
CHR had an Average Return On Invested Capital over the past 3 years of 5.30%. This is in line with the industry average of 5.85%.
The last Return On Invested Capital (6.29%) for CHR is above the 3 year average (5.30%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -17.42% | ||
| ROE | -47.8% | ||
| ROIC | 6.29% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
1.3 Margins
CHR has a Operating Margin of 6.77%. This is in the better half of the industry: CHR outperforms 66.67% of its industry peers.
In the last couple of years the Operating Margin of CHR has declined.
With an excellent Gross Margin value of 65.04%, CHR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of CHR has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.77% | ||
| PM (TTM) | N/A | ||
| GM | 65.04% |
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
2. Health
2.1 Basic Checks
CHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CHR has less shares outstanding
The number of shares outstanding for CHR has been increased compared to 5 years ago.
The debt/assets ratio for CHR has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.83, we must say that CHR is in the distress zone and has some risk of bankruptcy.
CHR's Altman-Z score of 0.83 is in line compared to the rest of the industry. CHR outperforms 44.44% of its industry peers.
The Debt to FCF ratio of CHR is 3.86, which is a good value as it means it would take CHR, 3.86 years of fcf income to pay off all of its debts.
CHR's Debt to FCF ratio of 3.86 is amongst the best of the industry. CHR outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.68 indicates that CHR is somewhat dependend on debt financing.
The Debt to Equity ratio of CHR (0.68) is better than 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | 3.86 | ||
| Altman-Z | 0.83 |
ROIC/WACC0.77
WACC8.2%
2.3 Liquidity
A Current Ratio of 1.22 indicates that CHR should not have too much problems paying its short term obligations.
CHR's Current ratio of 1.22 is fine compared to the rest of the industry. CHR outperforms 66.67% of its industry peers.
A Quick Ratio of 0.71 indicates that CHR may have some problems paying its short term obligations.
CHR has a Quick ratio of 0.71. This is comparable to the rest of the industry: CHR outperforms 55.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.71 |
3. Growth
3.1 Past
The earnings per share for CHR have decreased by -5.14% in the last year.
Measured over the past years, CHR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -19.03% on average per year.
The Revenue for CHR has decreased by -14.15% in the past year. This is quite bad
The Revenue has been growing slightly by 0.56% on average over the past years.
EPS 1Y (TTM)-5.14%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%35.71%
Revenue 1Y (TTM)-14.15%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-18.31%
3.2 Future
Based on estimates for the next years, CHR will show a small growth in Earnings Per Share. The EPS will grow by 5.59% on average per year.
Based on estimates for the next years, CHR will show a small growth in Revenue. The Revenue will grow by 0.78% on average per year.
EPS Next Y52.62%
EPS Next 2Y12.88%
EPS Next 3Y5.59%
EPS Next 5YN/A
Revenue Next Year-2.29%
Revenue Next 2Y-2.03%
Revenue Next 3Y0.78%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 12.11, the valuation of CHR can be described as correct.
Based on the Price/Earnings ratio, CHR is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
CHR is valuated cheaply when we compare the Price/Earnings ratio to 25.82, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 10.45, the valuation of CHR can be described as reasonable.
88.89% of the companies in the same industry are more expensive than CHR, based on the Price/Forward Earnings ratio.
CHR is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.11 | ||
| Fwd PE | 10.45 |
4.2 Price Multiples
88.89% of the companies in the same industry are more expensive than CHR, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHR indicates a rather cheap valuation: CHR is cheaper than 88.89% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.92 | ||
| EV/EBITDA | 4.8 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y12.88%
EPS Next 3Y5.59%
5. Dividend
5.1 Amount
CHR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:CHR (5/23/2025, 7:00:00 PM)
20.11
-0.11 (-0.54%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)
Earnings (Next)
Inst Owners1.95%
Inst Owner ChangeN/A
Ins Owners1.18%
Ins Owner ChangeN/A
Market Cap532.11M
Analysts78.18
Price Target27.36 (36.05%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-7.29%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.69%
Min EPS beat(2)3.87%
Max EPS beat(2)25.51%
EPS beat(4)3
Avg EPS beat(4)39.29%
Min EPS beat(4)-80.2%
Max EPS beat(4)207.96%
EPS beat(8)4
Avg EPS beat(8)7.83%
EPS beat(12)5
Avg EPS beat(12)1.78%
EPS beat(16)7
Avg EPS beat(16)0.15%
Revenue beat(2)0
Avg Revenue beat(2)-3.86%
Min Revenue beat(2)-3.95%
Max Revenue beat(2)-3.78%
Revenue beat(4)0
Avg Revenue beat(4)-6.49%
Min Revenue beat(4)-10.27%
Max Revenue beat(4)-3.78%
Revenue beat(8)3
Avg Revenue beat(8)-1.85%
Revenue beat(12)5
Avg Revenue beat(12)-1.08%
Revenue beat(16)9
Avg Revenue beat(16)6.44%
PT rev (1m)-1.57%
PT rev (3m)607.15%
EPS NQ rev (1m)3.99%
EPS NQ rev (3m)682.76%
EPS NY rev (1m)2.32%
EPS NY rev (3m)652.21%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)-0.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.91%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.11 | ||
| Fwd PE | 10.45 | ||
| P/S | 0.38 | ||
| P/FCF | 4.92 | ||
| P/OCF | 3.57 | ||
| P/B | 1.03 | ||
| P/tB | 1.05 | ||
| EV/EBITDA | 4.8 |
EPS(TTM)1.66
EY8.25%
EPS(NY)1.92
Fwd EY9.57%
FCF(TTM)4.09
FCFY20.35%
OCF(TTM)5.63
OCFY28.02%
SpS52.58
BVpS19.47
TBVpS19.13
PEG (NY)0.23
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -17.42% | ||
| ROE | -47.8% | ||
| ROCE | 8.48% | ||
| ROIC | 6.29% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 6.8% | ||
| OM | 6.77% | ||
| PM (TTM) | N/A | ||
| GM | 65.04% | ||
| FCFM | 7.78% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexcg growth 3Y33.52%
ROICexcg growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | 3.86 | ||
| Debt/EBITDA | 1.9 | ||
| Cap/Depr | 45.9% | ||
| Cap/Sales | 2.93% | ||
| Interest Coverage | 1.46 | ||
| Cash Conversion | 81.41% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z | 0.83 |
F-Score6
WACC8.2%
ROIC/WACC0.77
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.14%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%35.71%
EPS Next Y52.62%
EPS Next 2Y12.88%
EPS Next 3Y5.59%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.15%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-18.31%
Revenue Next Year-2.29%
Revenue Next 2Y-2.03%
Revenue Next 3Y0.78%
Revenue Next 5YN/A
EBIT growth 1Y-59.15%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year78.26%
EBIT Next 3Y15.88%
EBIT Next 5YN/A
FCF growth 1Y-55.84%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-51.04%
OCF growth 3Y12.73%
OCF growth 5Y0.25%